Advent in proteins, nucleic acids, and biological cell membranes functionalized nanocarriers to accomplish active or homologous tumor targeting for smart amalgamated chemotherapy/photo-therapy: A review

• Published in: International journal of biological macromolecules 2023-12, Vol.253 (Pt 8), p.127460, Article 127460
• Main Authors: Agwa, Mona M., Elmotasem, Heba, Moustafa, Rehab I., Abdelsattar, Abdallah S., Mohy-Eldin, Mohamed S., Fouda, Moustafa M.G.
• Format: Article
• Language: English
• Subjects: Active targeting; antibodies; cancer therapy; Cell Membrane; cell membranes; Combinatorial chemotherapy photo-therapy; Drug Delivery Systems; drug therapy; heat; Homologous targeting; Humans; irradiation; lactoferrin; ligands; metastasis; multiple drug resistance; nanocarriers; Nanoparticles; neoplasms; Neoplasms - drug therapy; Neoplasms - pathology; NIR laser; Nucleic Acids; oligonucleotides; Photo-dynamic therapy; Photo-thermal therapy; Photosensitizing Agents - pharmacology; radiotherapy; surgery; toxicity
• ISSN: 0141-8130; 1879-0003; 1879-0003
• DOI: 10.1016/j.ijbiomac.2023.127460

Conventional cancer mono-therapeutic approaches including radiotherapy, surgery, and chemotherapy don't always achieve satisfactory outcomes and are frequently associated with significant limitations. Although chemotherapy is a vital intervention, its effectiveness is frequently inadequate and is associated with metastasis, multidrug resistance, off-target effect, and normal cells toxicity. Phototherapies are employed in cancer therapy, encompassing photo-dynamic and photo-thermal therapies which under favorable NIR laser light irradiation initiate the included photosensitizers and photo-thermal agents to generate ROS or thermal heat respectively for cancer cells destruction. Photo-therapy is considered noninvasive, posing no resistance, but it still suffers from several pitfalls like low penetration depth and excessive heat generation affecting neighboring tissues. Improved selectivity and tumor-homing capacity could be attained through surface modulation of nanoparticles with targeting ligands that bind to receptors, which are exclusively overexpressed on cancerous cells. Developing novel modified targeted nanoparticulate platforms integrating different therapeutic modalities like photo-therapy and chemotherapy is a topic of active research. This review aimed to highlight recent advances in proteins, nucleic acids, and biological cell membranes functionalized nanocarriers for smart combinatorial chemotherapy/photo-therapy. Nanocarriers decorated with precise targeting ligands, like aptamers, antibody, and lactoferrin, to achieve active tumor-targeting or camouflaging using various biological cell membrane coating are designed to achieve homologous tumor-targeting. [Display omitted]